David Chin Yee, MD
Retina Specialist · Atlanta, GANPI 1740424563
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $597,618 of the $816,094 with a category attached, or 73.2%. 33 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 35.8% of the total.
Across 1,044 payments — averaging $781.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$292K
- Astellas Pharma US Inc$154K
- Apellis Pharmaceuticals, Inc.$138K
- Genentech USA, Inc.$115K
- Alimera Sciences, Inc.$41K
- Novartis$36K
- plus $39K from 27 others
Across 68 payments — averaging $1455.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$98K
- Notal Vision, Inc.$1K
What the payments were for
- Consulting fees$106,18813%
- Speaking & faculty fees$597,61873%
- Travel & lodging$83,00110%
- Food & beverage$29,2484%
- Gifts$390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 305 | $292,358 |
| Astellas Pharma US Inc | 129 | $154,073 |
| Apellis Pharmaceuticals, Inc. | 154 | $138,490 |
| Genentech USA, Inc. | 154 | $115,392 |
| Alimera Sciences, Inc. | 69 | $41,263 |
| Novartis | 52 | $35,963 |
| Regeneron | 16 | $12,529 |
| Eyepoint US, Inc. | 20 | $5,503 |
| F. Hoffmann-la Roche AG | 2 | $4,572 |
| Neurotech Pharmaceuticals, Inc. | 1 | $3,155 |
| Alcon | 12 | $3,125 |
| ANI Pharmaceuticals, Inc. | 18 | $3,084 |
| Bausch & Lomb Americas Inc. | 16 | $1,786 |
| AbbVie(2 entities) | 48 | $1,688 |
| Notal Vision, Inc. | 9 | $821 |
| Alcon Research LLC | 1 | $500 |
| Biogen | 8 | $270 |
| Carl Zeiss Meditec USA, Inc. | 2 | $253 |
| NEW World Medical,inc. | 1 | $210 |
| Sight Sciences, Inc. | 1 | $147 |
| Dompe US, Inc. | 2 | $137 |
| Rxsight Inc | 1 | $125 |
| Harrow Eye, LLC | 3 | $121 |
| Kala Pharmaceuticals, Inc. | 6 | $120 |
| Samsara Vision | 1 | $114 |
| Coherus Oncology, Inc. | 3 | $90 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $42 |
| Carl Zeiss Meditec AG | 2 | $39 |
| Sandoz | 1 | $37 |
| Ocular Therapeutix, Inc. | 1 | $27 |
| Sun Pharmaceutical Industries Inc. | 1 | $23 |
| LKC Technologies, Inc. | 1 | $19 |
| Astellas Pharma Global Development | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYLEA HD$242,771
- Izervay$142,388
- VABYSMO$102,856
- Syfovre$99,875
- EYLEA$57,892
- Iluvien$40,198
- Lucentis$12,944
- YUTIQ$8,675
- BEOVU$7,590
- EYP-1901$3,364
- PURIFIED CORTROPHIN GEL$2,448
- XIPERE$1,396
- OZURDEX$528
- NGENUITY$523
- SUSVIMO$509
- Constellation$410
- Kahook Dual Blade$210
- Clearpath$210
- Ahmed Glaucoma Valve$210
- Streamline$210
How this compares
Too few retina specialist providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 143 | $7,706 |
| Atropine Sulfate | 59 | $2,485 |
| Brimonidine Tartrate | 27 | $1,919 |
| Ketorolac Tromethamine | 50 | $1,460 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 62 | $776 |
| Latanoprost | 33 | $703 |
| Ciprofloxacin Hcl | 54 | $674 |
| Dorzolamide Hcl | 21 | $375 |
| MoxifloxacinMoxifloxacin Hcl | 11 | $335 |
| Timolol Maleate | 31 | $327 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Atlanta
- Daniel OhAtlanta$58K
- Sruthi ArepalliAtlanta$30K
- James FrankAtlanta$4K
- Nihaal MehtaAtlanta$468
- Ranjit DhaliwalAugusta$18K
- Oksana DemediukAugusta$16K
- Alexander BottiniBraselton$7K
- Kareem SioufiMarietta$6K
- Dimple ModiRome$3K
- Sohail KhanAugusta$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.